Stephen D. Gardner
- Epidemiology top 0.5%
- Hepatology top 0.2%
- Infectious Diseases top 5%
- Pharmacology top 2%
- Complementary and alternative medicine top 2%
- Co-authors
- Eugene R. SchiffJules L. DienstagMary WoessnerNancy LittleNancy LeungDF GrayE. Jenny HeathcoteChing‐Lung Lai
- Topics
- Hepatitis C virus research (27 papers)Liver Disease Diagnosis and Treatment (20 papers)Hepatitis B Virus Studies (19 papers)
- Cited by
- HepatologyEpidemiologyPharmacology
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Stephen D. Gardner
37 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Epidemiology 3.1k
- Hepatology 3.0k
- Infectious Diseases 405
- Pharmacology 221
- Complementary and alternative medicine 187
Countries citing papers authored by Stephen D. Gardner
This map shows the geographic impact of Stephen D. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Gardner more than expected).
Fields of papers citing papers by Stephen D. Gardner
This network shows the impact of papers produced by Stephen D. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Gardner. The network helps show where Stephen D. Gardner may publish in the future.
Co-authorship network of co-authors of Stephen D. Gardner
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. Gardner. A scholar is included among the top collaborators of Stephen D. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. Gardner. Stephen D. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 11 | |
| 5 | 11 | |
| 6 | 63 | |
| 7 | 100 | |
| 8 | 66 | |
| 9 | 117 | |
| 10 | 288 | |
| 11 | 27 | |
| 12 | 201 | |
| 13 | 150 | |
| 14 | 36 | |
| 15 | 66 | |
| 16 | 181 | |
| 17 | Long-term safety of lamivudine treatment in patients with chronic hepatitis Bbreakdown → | 596 |
| 18 | 197 | |
| 19 | 238 | |
| 20 | 31 |
About Stephen D. Gardner
Stephen D. Gardner is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 39 papers that have together received 3.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (27 papers), Liver Disease Diagnosis and Treatment (20 papers) and Hepatitis B Virus Studies (19 papers). The work is most often cited by research in Hepatology (3.0k citations), Epidemiology (3.1k citations) and Pharmacology (221 citations). Stephen D. Gardner has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Eugene R. Schiff, Jules L. Dienstag, Mary Woessner, Nancy Little, Nancy Leung, DF Gray, E. Jenny Heathcote, Ching‐Lung Lai, Robert Goldin and Sally L. Stephenson. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.